BIEL's easiest, fastest and most likely path to su
Post# of 8286
(Total Views: 70)
Posted On: 05/12/2025 11:42:23 PM
BIEL's easiest, fastest and most likely path to success is to generate a $400k revenue quarter and/or a $1.5 million revenue year (or if management hints Q1 2025 was profitable, or Q2 will be). A $400k revenue quarter would achieve cash flow positive/profitability and increase the pps to copper, which would solve most of BIEL's problems and open up a world of opportunities for the company.
BIEL COULD HIT COPPER IN THE "BLINK OF AN EYE"!
The first catalyst will likely be the announcement of a partner for the USA, which could come any day. The key statement from the annual report is "The Company has focused attention on seeking a distribution and licensing partner for the OTC US market". If investors value this partnership at $300k (and add it to the $496k of mostly international revenue reported for 2024), the pps gets out of the trips. If the investor valuation is $1 million, then the pps hits COPPER! The last time this happened (KT deal in 2021), BIEL soared 1,600%.
BIEL IS SIMPLE TO ANALYZE!
Q3 2021 was BIEL's only profitable quarter ($22,381) with $414,700 revenue (including $100k+ in covid relief funds). PROFITABILITY IS VERY CLOSE! Seems like $1.5 million annual revenue (or a $400k quarter) should do it, due to BIEL's extremely low operating costs and business model. Then the corresponding pps should hit .01 - and increase .01 for each additional $2.5 million annual revenue (P/E = 100). The $40 million tax-loss carry forward will make the first $40 million in profits tax free and accelerate the path to profitability.
BIEL COULD HIT COPPER IN THE "BLINK OF AN EYE"!
The first catalyst will likely be the announcement of a partner for the USA, which could come any day. The key statement from the annual report is "The Company has focused attention on seeking a distribution and licensing partner for the OTC US market". If investors value this partnership at $300k (and add it to the $496k of mostly international revenue reported for 2024), the pps gets out of the trips. If the investor valuation is $1 million, then the pps hits COPPER! The last time this happened (KT deal in 2021), BIEL soared 1,600%.
BIEL IS SIMPLE TO ANALYZE!
Q3 2021 was BIEL's only profitable quarter ($22,381) with $414,700 revenue (including $100k+ in covid relief funds). PROFITABILITY IS VERY CLOSE! Seems like $1.5 million annual revenue (or a $400k quarter) should do it, due to BIEL's extremely low operating costs and business model. Then the corresponding pps should hit .01 - and increase .01 for each additional $2.5 million annual revenue (P/E = 100). The $40 million tax-loss carry forward will make the first $40 million in profits tax free and accelerate the path to profitability.
(0)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼